Micro‐dystrophins are unlikely to fully replace the function of full‐length dystrophin inside a DMD cell, so it may be necessary to increase the amount of full‐length or near full‐length dystrophin to treat DMD. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.